Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Molecular Absorption Scanning and Assay of Serotonin Reception Inhibitor Antidepressant Drugs

Author(s): Amanda Santana Silva, Victor Hugo Abreu de Paula, Lucas Gabriel dos Santos Xavier, Ludimila Nascimento da Silva, Ana Carolyne Silva Lucas, Aléxia Mariany Lourenço Alves and Fernando Machado dos Santos*

Volume 20, Issue 1, 2024

Published on: 16 January, 2024

Page: [29 - 36] Pages: 8

DOI: 10.2174/0115734129282354231226192406

Price: $65

Abstract

Background: Spectrophotometric techniques are based on the absorption of electromagnetic energy by the molecules of the substance analyzed and can be applied to drug analysis.

Objective: This study has been proposed to carry out molecular absorption scanning and assay in the ultraviolet region of generic antidepressant drugs of the serotonin reuptake inhibitor class produced by three Brazilian laboratories, addressing the importance of good manufacturing practices, drug quality control, and the use of qualitative and quantitative analytical techniques.

Methods: The physicochemical analyses were performed in a Marte Científica (580 UVP) UV-Vis spectrophotometer, and the result was evaluated according to the acceptance interval described in the Brazilian Pharmacopoeia.

Results: When calculating the dosage of the fluoxetine hydrochloride sample, the value of 90.95% was obtained and, therefore, the drug was approved for the dosage test. The dosage test for the drugs, citalopram hydrobromide and sertraline hydrochloride, was also approved, obtaining values of 102.4% and 98.2%, respectively.

Conclusion: The results presented provide future perspectives regarding the rigor of the need for good drug handling practices, maintenance and qualification of quality control laboratory equipment, and the guarantee of validation of analytical methodologies used in the pharmaceutical industries, contributing to the improvement of the quality of production and pharmaceutical products analysis.

« Previous Next »
Graphical Abstract

[1]
Hammad, T.A.; Laughren, T.; Racoosin, J. Suicidality in pediatric patients treated with antidepressant drugs. Arch. Gen. Psychiatry, 2006, 63(3), 332-339.
[http://dx.doi.org/10.1001/archpsyc.63.3.332] [PMID: 16520440]
[2]
Castrén, E. Neurotrophic effects of antidepressant drugs. Curr. Opin. Pharmacol., 2004, 4(1), 58-64.
[http://dx.doi.org/10.1016/j.coph.2003.10.004] [PMID: 15018840]
[3]
Vismari, L.; Alves, G.J.; Palermo-Neto, J. Depression, antidepressants and the immune system: A new look at an old problem. Arch. Clin. Psychiatry, 2008, 35(5), 196-204.
[http://dx.doi.org/10.1590/S0101-60832008000500004]
[4]
Perez-Caballero, L.; Torres-Sanchez, S.; Romero-López-Alberca, C.; González-Saiz, F.; Mico, J.A.; Berrocoso, E. Monoaminergic system and depression. Cell Tissue Res., 2019, 377(1), 107-113.
[http://dx.doi.org/10.1007/s00441-018-2978-8] [PMID: 30627806]
[5]
Halperin, D.; Reber, G. Influence of antidepressants on hemostasis. Dialogues Clin. Neurosci., 2007, 9(1), 47-59.
[http://dx.doi.org/10.31887/DCNS.2007.9.1/dhalperin] [PMID: 17506225]
[6]
Hyttel, J. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int. Clin. Psychopharmacol., 1994, 9(Suppl. 1), 19-26.
[http://dx.doi.org/10.1097/00004850-199403001-00004] [PMID: 8021435]
[7]
Bastos, T. The neurobiology of depression. Masters dissertation., Porto: University of Porto, 2011.
[8]
Neves, A.L. Pharmacological treatment of depression. Masters dissertation., Porto: Fernando Pessoa University, Faculty of Pharmaceutical Sciences, 2015.
[9]
Williams, K.; Brignell, A.; Randall, M.; Silove, N.; Hazell, P. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Libr., 2013, (8), CD004677.
[http://dx.doi.org/10.1002/14651858.CD004677.pub3] [PMID: 23959778]
[10]
Bonenfant, D.; Mimeault, M.; Niquette, P.; Hausler, R. Adsorption study of a commonly used antidepressant drug, fluoxetine hydrochloride, onto a crosslinked β-cyclodextrin-carboxymethyl-cellulose polymer. Water Sci. Technol., 2012, 66(1), 224-230.
[http://dx.doi.org/10.2166/wst.2012.112] [PMID: 22678222]
[11]
Wong, D.T.; Perry, K.W.; Bymaster, F.P. Case history: The discovery of fluoxetine hydrochloride (Prozac). Nat. Rev. Drug Discov., 2005, 4(9), 764-774.
[http://dx.doi.org/10.1038/nrd1821] [PMID: 16121130]
[12]
Naveed, S.; Qamar, F.; Abbas, S.S.; Zehra, S.; Kirn, S.; Barkat, Z. Comparrative assay of citalopram in different media. J. Bioequiv. and Bioavail, 2015, 7(4), 194-196.
[13]
Raza, A. Development and application of spectrophotometric methods for the determination of citalopram hydrobromide in dosage forms. Chem. Pharm. Bull., 2006, 54(4), 432-434.
[http://dx.doi.org/10.1248/cpb.54.432] [PMID: 16595940]
[14]
Grubb, B.P.; Samoil, D.; Kosinski, D.; Kip, K.; Brewster, P. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J. Am. Coll. Cardiol., 1994, 24(2), 490-494.
[http://dx.doi.org/10.1016/0735-1097(94)90308-5] [PMID: 8034887]
[15]
National Health Surveillance Agency. In: Brazilian Pharmacopoeia, 6th ed.; v. 2. Brasilia, 2019.
[16]
Nagaraju, P.T.; Venugopal, K.; Murali, K.N.V.; Ragalatha, P.; Mani, P.; Mounika, T. Analytical method development and validation of sertraline in pure form by using UV spectrophotometry. World J. Pharm. Res., 2017, 6(4), 1594-1603.
[17]
Araújo, E.R. Validation of a UV-VIS spectrophotometric and spectrofluorimetric method for determining red dye of biotechnological origin associated with nanocarriers. Masters dissertation. São Paulo: Universidade Estadual Paulista Júlio de Mesquita Filho, 2019.
[18]
Silva, D.K.; Andrade, F.M. Pharmacogenetics of selective serotonin reuptake inhibitors: A review. In: Rev. Psychiatry of Rio Grande do Sul; , 2008; p. 30.
[19]
Lotfy, H.M.; El-Hanboushy, S.; Fayz, Y.M.; Abdelkawy, M. Smart spectrophotometric methods for concurrent determination of furosemide and spironolactone mixture in their pharmaceutical dosage forms. Braz. J. Pharm. Sci., 2022, 58, e19487.
[http://dx.doi.org/10.1590/s2175-97902022e19487]
[20]
Maluf, D.F.; Nagata, N.; Farago, P.V.; Zamora, P.G.P. Simultaneous determination of paracetamol and caffeine by UV-Vis spectrometry associated with mathematical tools. Rev. Bras. Farm., 2008, 89(1), 39-43.
[21]
Canassa, T.A.; Lamonato, A.L.; Ribeiro, A.V. Use of the Lambert-Beer law to determine the concentration of solutions. J. Experim. Techn. and Instr, 2018, 1(2), 23-30.
[22]
Passos, M.L.; Saraiva, M.L.M. Detection in UV-visible spectrophotometry: Detectors, detection systems, and detection strategies. Measurement, 2019, 135, 896-904.
[http://dx.doi.org/10.1016/j.measurement.2018.12.045]
[23]
National Health Surveillance Agency (Brazil). RDC Resolution No. 166, of July 24, 2017. Provides for the validation of analytical methods and provides other measures; Anvisa: Brasília, 2017.
[24]
Silva, J.R.; Vargem, D.S.; Lemes, E.O.; Moura, A.F. Validation of fluoxetine hydrochloride methodology. Essays and Science: Biological Sciences. Agrarian and Health, 2013, 17(4), 99-106.
[25]
Wingert, N.R.; Gomes, P.; Paim, C.S.; Schapoval, E.E.S.; Steppe, M. Quantitative analysis of duloxetine capsules by ultraviolet spectrophotometry and high-performance liquid chromatography. Health Science, 2008, 20-24.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy